| | |
C.H. Unnikrishnan 11:50 PM | November 17,2009
Pfizer’s top executives are scheduled to visit Mumbai for talks, but Wockhardt says it’s in no hurry to sell assets
|
|
Radhieka Pandeya 09:42 PM | November 08,2009
Govt and non-state domains should work together to combat diseases such as the H1N1 flu: health experts
|
|
Reuters 09:52 AM | October 29,2009
Wockhardt has said it plans to sell some non-core assets and recently got lenders approval to restructure debt
|
|
C.H. Unnikrishnan 10:57 PM | October 26,2009
Pfizer Inc., the world’s largest drug maker, bought Wyeth in January in a $68 billion (around Rs3.2 trillion) global deal
|
|
Reuters 02:30 PM | October 23,2009
Pfizer has tapped Cadila Healthcare, Emcure, Intas Pharma and Mankind Pharma, but the Indian companies have not responded favourably to the offers, the Economic Times said
|
|
Reuters 07:13 PM | October 20,2009
The world’s biggest drugmaker, which got much bigger last week with completion of a $67.3 billion acquisition of Wyeth, posted a net profit of $2.88 billion, or 43 cents per share in its last pre-merger quarter
|
|
12:46 AM | September 11,2009
Pfizer plans to get into market for generics; inflation falls for the thirteenth straight week; the National Innovation Project could lose its World Bank funding
|
|
C.H. Unnikrishnan 11:56 PM | September 10,2009
Firm to take on rivals by launching versions of top-selling drugs, to address both chronic and infectious diseases
|
|
Pratish Narayanan / Reuters 10:47 AM | August 06,2009
More tie-ups likely between global, Indian pharma firms; Pfizer, Merck,Sanofi may be on lookout for deals; Cipla, Aurobindo seen as potential targets;global firms seen benefitting from low costs in India; Indian firms to gain expertise, avoid legal battles
|
|
AP 06:12 PM | July 23,2009
Wyeth said its net income amounted to $1.27 billion, or 94 cents per share. That’s up from $1.12 billion, or 83 cents a share, a year earlier
|
|
AFP 05:20 PM | July 22,2009
Pfizer said results were hurt by the loss of US exclusivity for its allergy treatment Zyrtec in January 2008, allowing generic drugmakers to offer alternatives
|
|
AP 10:27 AM | July 21,2009
In the second quarter of 2008, 28 health care concerns reported spending at least $1 million lobbying
|
|
12:57 AM | June 20,2009
Expectations are high for this year’s budget; the Bombay High Court ruling on Reliance Industries hits the government’s gas policy; the CPI(M) meets to discuss its losses in the general elections
|
|
Shannon Pettypiece / Bloomberg 01:15 AM | June 15,2009
The company said this was its first session with managers of both genders to focus on women employees in developing nations, including China, India and Brazil
|
|
C.H. Unnikrishnan and Anup Roy 12:53 AM | June 15,2009
US firm in talks to snap up the struggling Indian drug maker’s biotech and veterinary divisions for around Rs120 crore
|
|